07
May

08:00 AM EDT

Chemistry, Manufacturing
and
Controls

Name: Medicinal Chemistry Strategy Meeting East Coast 2025 (Boston)
Start: 2025-05-08T08:00
End: 2025-05-08T18:00
Location: Le Méridien Boston Cambridge

Strategy Meeting East Coast USA 2025

The premier meeting for all East Coast USA CMC professionals

Le Meridien Cambridge

Our Event Starts In

–
days

–
hours

–
minutes

–
seconds

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh CMC Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered. Proventa International’s Manufacturing Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join CMC professionals from across the East Coast, in Boston MA, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We've partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our Facilitators

Our panel of facilitators plays a key role in shaping the agenda for the day. Whilst we're busy connecting with the best industry experts, take a look at our facilitators.

Blair McNeill

Senior Vice President, Head of Cell Therapy Sumitomo Pharma America

Session – Current processes and future considerations for Upstream and Downstream Viral Vector Production
Bian McNeill is a principal scientist by trade and an expert in Biologics CMC; leads research, pharmaceutical development, process development and clinical/commercial manufacturing of numerous companies’ early-stage product pipelines. His expertise is in protein chemistry/cell and molecular biology with extensive experience in protein expression, purification, and assay development, as well as gene therapy development and manufacturing. Brian has worked extensively with startup organizations, one such business unit recently selling for $900M. He has established new technologies in existing companies, with the last employer’s lead molecule clinical and commercial manufacturing process coming from the group created and led by him. Additionally, Brian has led collaborations across cross-functional teams both internally and externally; having an extensive background working with and in CDMOs both stateside and in Europe for both drug substance and drug product.
Brian has received his MS in Protein Chemistry from California State University. He went on to received a PhD in Molecular Physiology and Biophysics from Vanderbilt University. To further this accolade, he was presented with anther PhD in Physiology and Biophysics from Vanderbilt University Medical Center.

Caitlyn Harvey

Vice President, Head of CMC Convergent Therapeutics, Inc.

Dana Callow

Founder & Managing Partner Boston Millennia Partners

Debasis Patra

Vice President, Head of CMC OliX Pharmaceuticals

Erin O’Brien

VHead, Process Chemistry Synthetic Molecule Process Developmen Takeda

Fabien Bonhoure

Senior Vice President Chemistry & Manufacturing SEQUENS

Gopi Vudathala

Global Head, Regulatory Affairs CMC Incyte

Gregory Papastoitsis

Chief Process and Manufacturing Office Ankyra Therapeutics

Henry Wolfe

Senior Vice President, Biologics CMC Centessa Pharmaceuticals

Jamie Gillette

Vice President, Head of Regulatory Cullinan Oncology

Jeff Chu

Co-Founder and Managing Partner Features Capital

Johan Evenäs

Chief Executive Officer RG Discovery

Jon Seal

Associate Director of Medicinal Chemistry SAI Life Sciences

Kelly Barret

Director of Discovery Business Development Sai Life Sciences

Kimberly Garko

Senior Vice President, Chief Technical Officer Akebia Therapeutics

Kwame Nti-Addae

Executive Director, Head of CMC Frontier Medicines

Mahesh Padval

Chief Pharmaceutical Development Officer Relay Therapeutics

Matt Barrows

Senior Vice President, CMC & Technical Operations Aviceda Therapeutics

Niels Svenstrup

Senior Vice President, Chemistry & Manufacturing PepGen

Paul Peng

Vice President, CMC City Therapeutics

Raj Manchanda

Chief Technical Operations Officer Neumora Therapeutics

Robert Matunas

Head, CMC Zehna Therapeutics

Seshu Tyagarajan

Chief Technical and Development Officer Candel Therapeutics

Stephan Krause

Executive Director, Cell Therapy Global Quality Bristol Myers Squibb

Vikram Sadineni

Vice President, Technical Development & Manufacturing Generate:Biomedicines

Yumiko Mizuno

Head, Plasma-Derived Therapies (PDT) Drug Product Development Takeda

Yu Qian

Director, Head of Analytical Project Leads Cell Therapies Novartis

See the agenda and facilitator line-up. Download the strategy meeting brochure for full details.

DOWNLOAD THE BROCHURE

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

There's only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter

Senior Decision Makers

All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Personalised Agendas

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we'll create a personalised agenda just for you

Private and Intimate Networking

Small group discussions, private meetings, networking drinks - however you choose to make those important connections our Strategy Meetings have the solution

Our Agenda

See Which Topics Are Up For Discussion

09:00 - 10:00

Roundtable Tracks

Intermediates & API
The Role of Intermediates in API Synthesis and Their Impact on CMC Regulatory Submissions (Topic TBC)

-Niels Svenstrup
Senior Vice President, Chemistry & Manufacturing
PepGen

Technology Transfer Analytical
Key CMC Considerations for Effective Planning and Collaboration in Complex Site Transfers (Topic TBC)

-Paul Peng
Vice President, CMC
City Therapeutics

Outsourcing / Process Research & Scale Up
Global Outsourcing: Navigating Regulatory Differences (Topic TBC)

-Matt Barrows
Senior Vice President, CMC & Technical Operations
Aviceda Therapeutics

Integrated Drug Development
Developing Robust Analytical Methods for Integrated CMC (Topic TBC)

-Seshu Tyagarajan
Chief Technical and Development Officer
Candel Therapeutics

Emerging / New Modalities
Discovering Future Innovations in Manufacturing Platforms (e.g., modular facilities, bioreactors) and How CMC Strategies will Evolve as the Landscape for New Modalities Matures (Topic TBC)

-Henry Wolfe
Senior Vice President, Biologics CMC
Centessa Pharmaceuticals

Drug Substance, Drug Product, Drug Delivery
Enhancing Drug Solubility, Stability, and Drug Delivery

-Mahesh Padval
Chief Pharmaceutical Development Officer
Relay Therapeutics

11:10 - 12:10

Roundtable Tracks

Intermediates & API
CMC Strategies for Highly Potent Compounds: From Development to Commercialization

Sponsor

Technology Transfer Analytical
Seamless Technology and Knowledge Transfer From The Bench To The Plant

Sponsor

Outsourcing / Process Research & Scale Up
Effective Strategies for Managing Impurities during API production of peptides and macrocycles

-Dr. Kyryl Popov
Senior, Business Development
RG Discovery

RG Discovery

Integrated Drug Development
Accelerating Time To Market Through Integrated Services

Sponsor

Emerging / New Modalities
Essential Process Methodologies, Analytical Techniques, and Manufacturing Considerations Critical for Success in Emerging Modalities

Sponsor

Drug Substance, Drug Product, Drug Delivery
Understanding the Growing Role of Drug-Device Combination Products and Delivery Systems

12:15 - 13:15

Roundtable Tracks

Intermediates & API
Implementing Robust Strategies to Mitigate Risks in the Supply Chain

-Erin O’Brien
VHead, Process Chemistry
Synthetic Molecule Process Developmen Takeda

Technology Transfer Analytical
Identifying Key Success Factors for Effective Biologics Technology Transfer (Topic TBC)

-Gopi Vudathala
Global Head, Regulatory Affairs CMC
Incyte

Outsourcing / Process Research & Scale Up
Evaluating the Pros and Cons of Outsourcing CMC Activities

-Gregory Papastoitsis
Chief Process and Manufacturing Office
Ankyra Therapeutics

Integrated Drug Development
Collaboration Between CMC and Clinical Teams for Seamless Development

-Blair McNeill
Senior Vice President, Head of Cell Therapy
Sumitomo Pharma America

Emerging / New Modalities
Gene Therapies: Overcoming CMC Challenges and Finding Solutions (Topic TBC)

-Yu Qian
Director, Head of Analytical Project Leads
Cell Therapies Novartis

Drug Substance, Drug Product, Drug Delivery
Tackling the Challenges and Innovations in Oral Drug Delivery (Topic TBC)

-Kwame Nti-Addae
Executive Director, Head of CMC
Frontier Medicines

15:10 - 16:10

Roundtable Tracks

Intermediates & API
Building a Successful Overall Development Plan for Producing Sufficiently Formulated API (Topic TBC)

-Jamie Gillette
Vice President, Head of Regulatory
Cullinan Oncology

Technology Transfer Analytical
Best Industry Practice for Late-Stage and Commercial Analytical Method Transfer (AMT)

-Stephan Krause
Executive Director, Cell Therapy Global Quality
Bristol Myers Squibb

Outsourcing / Process Research & Scale Up
Building Scalable and Flexible CMC Strategies: Leveraging CDMO Partnerships and Digital Tools from Early Development to Commercialization

-Vikram Sadineni
Vice President, Technical Development & Manufacturing
Generate:Biomedicines

Integrated Drug Development
Leveraging Digital Tools for Integrated CMC (Topic TBC)

-Art Faulkner
Vice President, Regulatory CMC
TG Therapeutics, Inc.

Emerging / New Modalities
Exploring Emerging Oligonucleotide Modalities and Their Implications for Therapeutic Development

-Debasis Patra
Vice President, Head of CMC
OliX Pharmaceuticals

Drug Substance, Drug Product, Drug Delivery
Innovation in Drug Delivery Systems (Topic TBC)

-Robert Matunas
Head, CMC
Zehna Therapeutics

Become an official strategy meeting partner. Whatever your business needs, we can help. Get in touch for partnering opportunities

Partner With US

Explore Highlight From The Past Events

Gain valuable insights, discover innovative solutions and connect with industry leaders through snapshots of our most successful gatherings.

May
2023

Jun
2020

Oct
2020

Press play to hear what your colleagues had to say...

Hotel & Venue

Le Méridien Boston Cambridge

Hotel Details Map & Directions Parking

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Manufacturing Boston

Clinical Operations & Clinical Trial Supply Chain Strategy Meeting East Coast – Boston 2024

Chemistry, Manufacturing and Controls

Strategy Meeting East Coast USA 2025

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Le Meridien Cambridge

Fresh CMC Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Meet Our Facilitators

Blair McNeill

Caitlyn Harvey

Dana Callow

Debasis Patra

Erin O’Brien

Fabien Bonhoure

Gopi Vudathala

Gregory Papastoitsis

Henry Wolfe

Jamie Gillette

Jeff Chu

Johan Evenäs

Jon Seal

Kelly Barret

Kimberly Garko

Kwame Nti-Addae

Mahesh Padval

Matt Barrows

Niels Svenstrup

Paul Peng

Raj Manchanda

Robert Matunas

Seshu Tyagarajan

Stephan Krause

Vikram Sadineni

Yumiko Mizuno

Yu Qian

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

Senior Decision Makers

Personalised Agendas

Private and Intimate Networking

Our Agenda

See Which Topics Are Up For Discussion

Registration Welcoming

Opening Keynote Presentation

Roundtable

Roundtable Tracks

Refreshment Break

Networking/1-1 Meetings

Roundtable

Roundtable Tracks

Sponsor

Sponsor

RG Discovery

Sponsor

Sponsor

Roundtable

Roundtable Tracks

Networking Lunch

Networking / 1-1 Meetings

Afternoon Keynote Presentation

Roundtable

Roundtable Tracks

Networking Lunch

Panel Discussion

Drinks Canapes & Reception

Our Sponsors

Co-Host Sponsors

Partnering Sponsor

Chemistry, Manufacturing
and
Controls

Le Meridien Cambridge